| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.48▼ | 2.48▼ | 2.48▼ | 2.41▲ | 2.47▼ |
| MA10 | 2.50▼ | 2.50▼ | 2.50▼ | 2.46▼ | 2.24▲ |
| MA20 | 2.52▼ | 2.52▼ | 2.52▼ | 2.51▼ | 1.79▲ |
| MA50 | 2.54▼ | 2.50▼ | 2.48▼ | 2.24▲ | 3.22▼ |
| MA100 | 2.52▼ | 2.68▼ | 2.83▼ | 1.98▲ | 75.59▼ |
| MA200 | 3.65▼ | 2.07▲ | 1.82▲ | 3.13▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.013▼ | -0.013▼ | -0.012▼ | -0.035▼ | 0.679▲ |
| RSI | 43.126▼ | 44.542▼ | 44.914▼ | 49.809▼ | 42.147▼ |
| STOCH | 62.654 | 52.835 | 50.155 | 45.000 | 15.430▼ |
| WILL %R | -57.407 | -58.928 | -58.928 | -53.125 | -84.906▼ |
| CCI | -112.542▼ | -118.497▼ | -119.894▼ | -86.273 | 19.386 |
|
Wednesday, March 11, 2026 06:44 AM
Through its investment in PsyLabs, Psyence BioMed has secured: A licensed, owned, and debt-free production operation. Source-level ibogaine supply. Natural psilocybin supply. GMP-compliant ...
|
|
Tuesday, March 03, 2026 01:15 AM
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine ...
|
|
Monday, February 23, 2026 06:42 AM
(RTTNews) - Psyence Biomedical Ltd. (PBM), a biopharmaceutical company, announced that Psyence Labs Ltd., a developer and manufacturer of pharmaceutical-grade psychedelic compounds, has exercised its ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/03/26 | 2.422 | 2.43 | 2.3601 | 2.43 | 8,096 |
| 24/03/26 | 2.3601 | 2.43 | 2.36 | 2.43 | 5,101 |
| 23/03/26 | 2.3801 | 2.47 | 2.3801 | 2.43 | 15,386 |
| 20/03/26 | 2.40 | 2.46 | 2.3043 | 2.40 | 5,150 |
| 19/03/26 | 2.59 | 2.59 | 2.28 | 2.35 | 19,055 |
| 18/03/26 | 2.60 | 2.60 | 2.52 | 2.54 | 9,762 |
| 17/03/26 | 2.50 | 2.59 | 2.40 | 2.59 | 15,878 |
| 16/03/26 | 2.41 | 2.57 | 2.4001 | 2.50 | 21,962 |
| 13/03/26 | 2.44 | 2.47 | 2.4106 | 2.46 | 3,163 |
| 12/03/26 | 2.46 | 2.51 | 2.43 | 2.46 | 8,860 |
|
|
||||
|
|
||||
|
|